SonoSite, Inc. (NASDAQ:SONO)

CAPS Rating: 4 out of 5

The Company deales in the development of HCU systems for use in a variety of medical specialties in a range of clinical settings.

Results 1 - 19 of 19

Recs

0
Member Avatar ddaemili (< 20) Submitted: 4/22/2010 11:34:23 PM : Outperform Start Price: $32.23 SONO Score: -5.10

Noolimmok

Recs

0
Member Avatar 3DeeFool (62.12) Submitted: 1/8/2010 7:25:51 AM : Outperform Start Price: $26.00 SONO Score: +24.28

This company popped up when I screened for high gross margin (>40%), high institutional ownership (>90%) and high cash per share (>$10) with a > 20% appreciation in stock price over the year.

Recs

0
Member Avatar izzydice (< 20) Submitted: 5/12/2009 9:56:30 PM : Outperform Start Price: $18.53 SONO Score: +56.22

Sonosite makes the best ultra sound products for emergency medicine. Ultrasound has become the modern day stethescope for an ER doctor. It is an inexpensive way to diagnose and detect internal bleeding and other serious symptoms. There are ER Dr.s that specialize in ultrasound. In the future, Doctors in other fields will eventually find the use of ultrasound.

Recs

0
Member Avatar Isolato (< 20) Submitted: 4/1/2009 3:48:48 PM : Outperform Start Price: $17.00 SONO Score: +57.39

Medical technology is one our "stimulus" goals. Sonosite is on the verge of giving us Dr. McCoy's tri-corder. They have broken through to profitability from the development stage. There are two possible outcomes. They do great all by themselves, GE buys them.

Recs

0
Member Avatar doggetla (55.06) Submitted: 10/30/2008 10:47:42 PM : Outperform Start Price: $20.40 SONO Score: +39.55

small cap growth in the healthcatre sector

see jsb8000 remarks

Recs

0
Member Avatar JSB8000 (32.90) Submitted: 3/6/2008 3:15:21 PM : Outperform Start Price: $28.75 SONO Score: +22.57

This stock is a bit risky. Most analysts predict great things for SONO's profits, but a few are fearful over its two patent infringement lawsuits. Nevertheless, consensus estimates are for eps growth of over 100% in 08 and close to 70% in 09. Long term growth is estimated at 75%/year for 3 to 5 years. Yet SONO is selling today (3/6/08) at only 21 x 09 earnings, a bargain. Even more remarkable, Morningstar calculates that SONO's PEG (price earnings to growth) ratio is only .3, which is extraordinarily low for any stock, particularly one in the medical world. If one is willing to accept a bit of legal risk, this stock could produce substantial returns. Looking at the odds, it might be a very good bet...

Recs

0
Member Avatar kneeley (< 20) Submitted: 11/14/2007 11:24:17 PM : Outperform Start Price: $33.87 SONO Score: +10.11

Healthcare markets are only going to be growing which bodes well for best-of-breed products.

Recs

0
Member Avatar TMFStockPick07 (20.44) Submitted: 5/21/2007 6:27:16 PM : Outperform Start Price: $28.00 SONO Score: +48.24

This stock was picked to outperform from May 2007 to May 2008 by TMFPhila

Recs

0
Member Avatar salmonfun (47.74) Submitted: 2/24/2007 8:03:23 PM : Outperform Start Price: $30.59 SONO Score: +24.49

GOOD GROWTH PROSPECTS

Recs

0
Member Avatar egenesis (84.12) Submitted: 2/17/2007 12:53:06 AM : Outperform Start Price: $30.56 SONO Score: +24.38

Innovative, not too high valuation, new company so p/e not very meaningful yet, good Wall St ratings

Recs

1
Member Avatar NetscribeHealthC (65.97) Submitted: 2/8/2007 8:14:47 AM : Outperform Start Price: $33.39 SONO Score: +8.58

SonoSite is a world leader in hand-carried ultrasound (HCU) specializing in development of HCU systems for use in a variety of medical specialties and a range of clinical settings. The company's HCU devices are designed for applications where ultrasound has not typically been used, such as emergency medicine, surgery, critical care, internal medicine and vascular access procedures as well as for imaging in traditional applications, such as radiology, cardiology, vascular medicine and obstetrics/gynecology.

Its products include MicroMaxx System, SonoSite 180PLUS, SonoHeart ELITE system and SonoSite TITAN system selling in over 75 countries. It derives 54% of its revenue from the U.S. market alone. The company sells its products through direct sales representatives, clinical application specialists and independent third-party distributors.

The worldwide market for traditional ultrasound imaging is estimated at $4 billion. As the market for high-performance HCU systems develops, competition has been increasing as potential and existing competitors enter the portable market or modify their existing products to more close approximate portability. The company’s competitors in the portable market include Siemens, GE Healthcare, Philips, Biosound, Medison America and Zonare Medical Systems. Ending 2005 the company was a market leader with nearly 40% share of the HCU market and GE had about 25% share.

Revenue reflects a compound annual growth rate (CAGR) of 35.7% during 2001-05 with the introduction of innovative products expanding the product line. Revenues for the initial three quarters of 2006 witnessed a 15% growth rate on the back on 16.2% growth in domestic sales and nearly 18% in international markets. Assuming increased use of HCUs for visual screening, strategic product pricing and increased sales penetration in China and Japan, the management expects the top-line to rise by 18-20% in 2007 making it a likely outperformer.

Recs

0
Member Avatar hbw5459 (< 20) Submitted: 10/19/2006 10:40:01 AM : Outperform Start Price: $28.38 SONO Score: +27.75

made a great buy recently

Recs

0
Member Avatar synergyltd (< 20) Submitted: 10/18/2006 7:31:47 PM : Outperform Start Price: $28.18 SONO Score: +29.01

stock has shown weak sales the past 2 quarters but is tops in it's area and will rebound in 2007

Recs

0
Member Avatar PacoKiser (< 20) Submitted: 10/13/2006 10:41:43 AM : Outperform Start Price: $29.94 SONO Score: +17.45

Profits currently going into growing business. Expect stock to go back to 40+.

Recs

0
Member Avatar samorse (< 20) Submitted: 10/4/2006 3:06:59 AM : Outperform Start Price: $28.64 SONO Score: +21.81

Portable ultrasound instruments are a wonderful invention.

Recs

0
Member Avatar Mothbeard (71.19) Submitted: 9/21/2006 4:49:51 PM : Outperform Start Price: $29.84 SONO Score: +13.97

The stock is now near a 52 week low, but they are the market leader in their industry and continue to show strong growth.

Recs

1
Member Avatar mqchristensen (94.00) Submitted: 9/5/2006 3:12:11 AM : Outperform Start Price: $31.05 SONO Score: +4.58

In addition to interesting growth prospects, Sonosite has a strong trackrecord of making the fixes necessary to get things back on track. I'd expect them to at least bounce back to their previous level of 40.

Recs

0
Member Avatar Nemo104 (56.62) Submitted: 8/31/2006 4:57:52 AM : Outperform Start Price: $30.85 SONO Score: +4.86

Solid product. Stock selling well below 52wk high, beginning to head North.

Recs

2
Member Avatar TMFBreakerJava (99.48) Submitted: 7/28/2006 7:41:47 PM : Outperform Start Price: $32.67 SONO Score: -8.00

This medical device company makes hand held ultrasound devices, which allows ultrasound to be applied far more conveniently and in settings where it would never have been used in the past. It is still in the early stages of adoption with much room for rapid growth ahead. It has recently become profitable and is expected to improve net margins. Furthermore it has been beaten down of late.

Results 1 - 19 of 19

Featured Broker Partners


Advertisement